SIStockInvestingSI.com

NASDAQ · IDXX · Diagnostics & Research

IDEXX Laboratories, Inc. (IDXX) stock analysis

$553.48−0.80%Data as of Oct 21, 2026
  • IDXX gained 6.1% over the past month versus 0.0% for the S&P 500, ranking 151st of 497 S&P 500 stocks.
  • Over 12 months it returned −14.0%, 29.8 points behind the S&P 500, and trades 27.8% below its 52-week high.
  • In the last 30 days 11 analysts raised earnings estimates and 2 cut; forward EPS moved 0.0% (+1.4% over 90 days).
  • It sits in the Animal health segment of the Healthcare Value Chain, where the 1-month median return is +7.7%.
  • The daily chart reads Trend transition · Trend repair (since Oct 20, 2026).
Market cap$43.6B
12-month return−14.0%
Forward P/E33.1×
Mean target vs price+27.5%

One-year price with 50- and 200-day averages

Open in Hub
526599672746JanAprJulOct
553.4850-day200-day

Performance vs the market

Total price return against the S&P 500 (SPY) and the median of US stocks in the same sector.

IDXX+6.1%
Sector median−8.7%
S&P 5000.0%
IDXX+2.6%
Sector median−5.4%
S&P 500+4.7%
IDXX−4.3%
Sector median−1.5%
S&P 500+8.7%
IDXX−14.0%
Sector median+1.7%
S&P 500+15.8%
1-month rank in the S&P 500151 / 497
1-month rank in the Nasdaq 10034 / 100
3-month rank in its sector · Healthcare278 / 720

Chart structure

Read by our daily-bar structure engine from swing highs, swing lows and moving averages.

Trend transition · Trend repairAwaiting confirmation

Holding since Oct 20, 2026

  • Price and averages have mixed alignment
  • EMA50 rose over the last ten sessions
  • Intermediate and long-term directions differ
  • Neither a stable trend nor a range is confirmed
This pattern on this stock

39 occurrences in 10 years. The median move over the next 20 sessions was +2.2%, positive 54% of the time, against +1.1% for any day in the same period.

Reference zone, stop and targets for this structureSee the trade plan in Hub ↗

Analyst earnings revisions

Changes to the consensus forward-EPS estimate. Rising estimates mean analysts see more profit ahead.

Forward EPS$16.74
30-day change0.0%
90-day change+1.4%
Mean target$705.50 +27.5%
Raised (30d) 11Cut (30d) 2

12 analysts cover the stock

Fundamental shape vs peers

Six dimensions on fixed scales. The filled shape is the company; the outline is the peer average.

Open the full Radar with every ratio
ValuationRevisionsMomentumGrowthCashProfit

Ahead of peersProfit, Revisions

Behind peersMomentum, Valuation

PeersTMO · DHR · NTRA · A

Where it sits in the supply chain

Healthcare Value Chain · Drugs & devices

Explore the full chain map in Hub
Its segment
Animal health+7.7%
ZTS+9.3%1 monthIDXX+6.1%1 month

Pet and livestock medicines and veterinary diagnostics, mostly self-pay, following vet visits and consumer spending.

Sells into
Patients, employers & pet owners

Figures are each company's 1-month return; the segment shows its median · Doubler daily batch · company chain maps

Risk profile

Max drawdown, 12M−34.2%
Volatility, 60D25.0%
From 52-week high−27.8%
From 52-week low+9.7%
Trailing P/E38.9×
Forward P/E33.1×
ZTSZoetis Inc.TMOThermo Fisher ScientificDHRDanaherAAgilent Technologies, Inc.IQVIQVIA Holdings, Inc.WATWaters CorporationMTDMettler-Toledo International, IDGXQuest Diagnostics Incorporated

Track this stock every day

Hub adds the daily brief, StockFlow factor flow, trade plans and alerts for your watchlist.

Open in Hub ↗